International Conference on One Health Antimicrobial Resistance

International Conference on One Health Antimicrobial Resistance

Programme

The programme comprises 7 sessions dedicated to AMR surveillance, transmission, antimicrobial stewardship, host adaptation of multidrug-resistant bacteria, diagnostics, phage therapy and microbiota modulation distributed over 3 days (2 half days and 1 full day). It also includes two roundtable discussions on hot topics. Topics included are
‘What is the meaning of One Health?’ and ‘Can alternatives replace conventional antibiotics?’, which will allow the audience to interact with the speakers on these relevant topics.

 

Day 1 (April 18th)

14.00-17.00

Registration

17.00-17-15

Welcome speech by the Organizing Committee

17.15-17.45

Opening keynote lecture by Till Bachmann (Chair of JPIAMR Scientific Advisory Board, UK): Opportunities and impact of AMR diagnostic solutions for One Health

17.45-19.30

Welcome reception  

 

Day 2 (April 19th)

9.00-9.45

Onehealth integrated surveillance or AMR. Chair: Sally Cutler (UK)

  • Tine Rikke Jorgensen (WHO): Research priorities for One Health surveillance
  • Frank Aarestrup (DK): AMR surveillance of sewage by metagenomics
 

9.45-10.30

Transfer of AMR between humans, animals and the environment. Chair: Dorina Timofte (UK)

  • Edward Feil (UK): A large-scale population snapshot of Klebsiella spp. reveals limited transmission of strains between clinical and non-clinical settings
  • Joakim Larsson (SE): The role of the environment in evolution, transmission and surveillance of antibiotic resistance
 

10.30-11.00

Coffee break

11.00-11.45

Antimicrobial stewardship. Chair: Els Broens (NL)

  • Lisbeth Rem Jessen (DK): Evidence-based guidelines for antimicrobial use in animals
  • Jeroen Schouten (NL): How to implement Antimicrobial stewardship programs in healthcare settings worldwide
 

11.45-12.30

Host adaptation by MDR bugs. Chair : Ross Fitzgerald (UK)

  • Marc Stegger (DK): The adaptation of E. coli and S. aureus to host and environment
  • Constance Schultsz (NL): The importance of host restriction on AMR transmission in Escherichia coli
 

12:30-14.15

Lunch and poster viewing

14.15-16:00

Joint ESGVM-ECVM-EAVLD session. Chair: Heather Graham (NL)

  • Augusta Pelosi (USA): One Heart, One Health
  • Selected abstracts for oral presentation
 

16.00-16.30

Coffee break

16.30-17.15

Roundtable discussion: “What is the meaning of One Health?”
Chair: Luca Guardabassi (DK); participants: all speakers from Day 2

17.15-19.30

Programme break

19.30-22.00

Social dinner TBA

 

Day 3 (April 20th)

9.00-9.45

Phage therapy. Chair: Ana Vale (IE)

  • Martha Clokie (UK): Bacteriophages as the ultimate One Health approach to antimicrobial resistance in animals and humans
  • Michela Gambino (DK): Phages against ETEC infections in pigs
 

9.45-10.30

Microbiota Modulation. Chair: David Dockrell (UK)

  • Ed Kuijper (NL): Risks and benefits of fecal microbiota transplantation
  • Birgitta Duim (NL): Competitive exclusion of MRSA in pigs
 

10.30-11.00

Coffee break

11.00-11.45

Roundtable discussion: “Can alternative therapies replace conventional antibiotics?”
Chair Patrick Butaye (B); participants: all speakers from Day 3

11.45-12.00

Award ceremony for young scientists

12.00-12.30

Closing keynote lecture by Lothar Wieler (President Robert Koch Institute, DE): The challenges of AMR, a pandemic in the shadows

12.30

Closing remarks by the Organizing Committe

 

Lunch package & refreshments